MedPath

A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002)

Phase 2
Terminated
Conditions
Pain, Postoperative
Registration Number
NCT00424424
Lead Sponsor
Merck Sharp & Dohme LLC
Brief Summary

This study is being conducted to evaluate the safety and tolerability of the drug and to evaluate its efficacy compared to placebo and to ibuprofen in the prevention of postoperative dental pain in male patients.

This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
81
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Proprietary Information - Exploratory (Non-Confirmatory) Trial
Secondary Outcome Measures
NameTimeMethod
Proprietary Information - Exploratory (Non-Confirmatory) Trial
© Copyright 2025. All Rights Reserved by MedPath